Number needed to treat and time to response/remission for quetiapine monotherapy efficacy in acute bipolar depression: evidence from a large, randomized, placebo-controlled study
The DOI matches its Crossref record; 6 of the 6 references it cites were found in a registry or an index.
Abstract
The objectives of this analysis are to elucidate the clinical significance of antidepressant effects with quetiapine by evaluating number needed to treat as well as time to response and remission with quetiapine monotherapy in patients with acute bipolar depression. A post-hoc analysis was conducted of 542 patients with bipolar I or II disorder, (moderate to severe depression), randomized to 8 weeks of double-blind treatment with quetiapine 600 mg/day (n=180), quetiapine 300 mg/day (n=181), or placebo (n=181). Number needed to treat, time to response (> or =50% reduction from baseline in Montgomery-Asberg Depression Rating Scale total score) and time to remission (Montgomery-Asberg Depression Rating Scale total score < or =12) were evaluated. Response rates at week 8 were 58.2 and 57.6% for quetiapine 600 and 300 mg/day, respectively, and 36.1% for placebo (P<0.001). Remission rates were 52.9% for both quetiapine groups and 28.4% for placebo (P<0.001). The number needed to treat was five for both response and remission for quetiapine (600 and 300 mg/day) compared with placebo. Median time to response and remission were significantly shorter with quetiapine 600 and 300 mg/day than placebo. No between-group difference was found in the incidence of treatment-emergent mania or hypomania (quetiapine 600 mg/day: 2.2%, quetiapine 300 mg/day: 3.9, and placebo: 3.9%). In conclusion, quetiapine compared with placebo significantly reduces time to response and remission compared with placebo, and has a favorable number needed to treat.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Calabrese, J. R., Bowden, C. L., Sachs, G. S., Ascher, J. A., Monaghan, E., Rudd, G. D., & The Lamictal 602 Study Group (1999) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v60n0203 · Cited by 1,054
Tohen, M., Vieta, E., Calabrese, J., Ketter, T. A., Sachs, G., Bowden, C., Mitchell, P. B., Centorrino, F., Risser, R., Baker, R. W., et al. (2003) · Archives of General Psychiatry · doi:10.1001/archpsyc.60.11.1079 · Cited by 908
Self-citationCalabrese, J. R., Keck, P. E., Macfadden, W., Minkwitz, M., Ketter, T. A., Weisler, R. H., Cutler, A. J., McCoy, R., Wilson, E., Mullen, J., et al. (2005) · American Journal of Psychiatry · doi:10.1176/appi.ajp.162.7.1351 · Cited by 883 · cited 8×
“These analyses confirm the results of the original publication that reported efficacy on the basis of the mean change in MADRS total score from baseline to last assessment and effect sizes (Calabrese et al., 2005).”
BackgroundMethodResultInfluentialSelf-citationPost, R. M., Denicoff, K. D., Leverich, G. S., Altshuler, L. L., Frye, M. A., Suppes, T. M., Rush, A. J., Keck, P. E., McElroy, S. L., Luckenbaugh, D. A., et al. (2003) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v64n0610 · Cited by 418 · cited 2×
“Introduction Despite the substantial burden associated with bipolar depression (Dilsaver et al., 1997; Altshuler et al., 2002; Post et al., 2003; Kupka et al., 2005), options for its treatment remain limited.”
BackgroundSelf-citationSubsyndromal Depression Is Associated With Functional Impairment in Patients With Bipolar Disorder
Altshuler, L. L., Gitlin, M. J., Mintz, J., Leight, K. L., & Frye, M. A. (2002) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v63n0910 · Cited by 174
Stabilization of Mood From Below Versus Above Baseline in Bipolar Disorder: A New Nomenclature
Ketter, T., & Calabrese, J. R. (2002) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v63n0210 · Cited by 161
Self-citation
Cited by
Treatment of bipolar disorder: a complex treatment for a multi-faceted disorder
Fountoulakis, K. N., Vieta, E., Siamouli, M., Valenti, M., Magiria, S., Oral, T., Fresno, D., Giannakopoulos, P., & Kaprinis, G. S. (2007) · Annals of General Psychiatry · doi:10.1186/1744-859x-6-27 · Cited by 76
“Quetiapine effectiveness in both mania and depression as monotherapy is supported by RCTs [59,69,131-139].”
The course of bipolar disorder
Saunders, K. E. A., & Goodwin, G. M. (2010) · Advances in Psychiatric Treatment · doi:10.1192/apt.bp.107.004903 · Cited by 56
“Quetiapine appears to have superior efficacy in acute bipolar depression and has been found to lead to remission in over 50% of patients (Cookson 2007).”
Lydiard, R. B., Culpepper, L., Schiöler, H., Gustafsson, U., & Paulsson, B. (2009) · The Primary Care Companion to The Journal of Clinical Psychiatry · doi:10.4088/pcc.08m00659 · Cited by 23
Metadata
- Authors
- Cookson, J., Keck, P. E., Ketter, T. A., & Macfadden, W.
- Venue
- International Clinical Psychopharmacology
- Published
- 2007-03
- Volume
- 22
- Issue
- 2
- Pages
- 93-100
- ISSN
- 0268-1315 (ISSN-L)
- OpenAlex
- W2068977695
- Cited by
- 39
- References
- 6
- FWCI
- 3.64
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Number needed to treat and time to response/remission for quetiapine monotherapy efficacy in acute bipolar depression: evidence from a large, randomized, placebo-controlled study. https://app.cochat.ai/papers/10.1097/yic.0b013e3280119dfb
- The paper
- Cookson, J., Keck, P. E., Ketter, T. A., & Macfadden, W. (2007). Number needed to treat and time to response/remission for quetiapine monotherapy efficacy in acute bipolar depression: evidence from a large, randomized, placebo-controlled study. International Clinical Psychopharmacology. https://doi.org/10.1097/yic.0b013e3280119dfb
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.